Construction and Periplasmic Expression of a Bispecific Tandem scFv for Dual Targeting of Immune Checkpoints. | Adv Biomed Res;12: 42, 2023. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Construction and Periplasmic Expression of a Bispecific Tandem scFv for Dual Targeting of Immune Checkpoints.

Rashti, Amirreza; Akbari, Vajihe.

Affiliation

Rashti A; Department of Pharmaceutical Biotechnology and Isfahan Pharmaceutical Research Center, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
Akbari V; Department of Pharmaceutical Biotechnology and Isfahan Pharmaceutical Research Center, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.

Adv Biomed Res ; 12: 42, 2023.

Article in En | MEDLINE | ID: mdl-37057231

Key words

Antibodies; CTLA-4; PD-1; bispecific; neoplasms; periplasmic expression

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Adv Biomed Res Year: 2023 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Adv Biomed Res Year: 2023 Document type: Article Affiliation country: Country of publication: